Cover Image

Association of Baldness with Coronary Artery Disease and Its Severity

Reza Arefi, Mehdi Pishgahi, Adel Joharimoghaddam, Mohammad Ali Momeni, Mehran Khoshfetrat
Background: The pivotal role of baldness as a potential risk factor for cardiovascular disorders remains a debate, and the small body of literature has generated inconsistent findings. We aimed to assess the association between baldness and the risk for coronary artery disease (CAD) and its severity in a sample of Iranian men. Materials and Methods: This cross-sectional study was performed on 105 consecutive patients suspected to CAD and scheduled for elective coronary angiography. The severity of CAD was determined according to the number of involved coronary vessels. For assessing the severity of baldness, the Hamilton-Norwood scale for grading of androgenetic alopecia in males was used. Results: The overall frequency of CAD in the groups with and without baldness was 88.9% and 72.5%, respectively, indicating a significant difference (P=0.033). Similarly, patients with the family history of baldness suffered more from CAD as compared to those without history (93.3% vs.76.0%). However, no significant association was found between the baldness and non-baldness groups with regard to the severity of CAD (P=0.291). According to the multivariable logistic regression model, the presence of baldness could predict the increased likelihood of CAD (or=3.037, P=0.046). Conclusion: Along with traditional risk factors for CAD, the presence of baldness and positive family history of this phenotype could be considered as the primary determinant for the increasing likelihood of CAD. [GMJ.2020;9:e1474]
Coronary Artery Disease; Baldness; Alopecia

Canto JG, Kiefe CI, Rogers WJ. NRMI Investigators. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120-7.

https://doi.org/10.1001/jama.2011.1654

PMid:22089719 PMCid:PMC4494683

Yayan J. Association of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertension. Clin Interv Aging. 2014;20;9:2003-12.

https://doi.org/10.2147/CIA.S74471

PMid:25429212 PMCid:PMC4242066

Zengin E, Bickel C, Schnabel RB, Zeller T, Lackner KJ, Rupprecht HJ, et al. Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--Study. PLoS One. 2015;8;10(7):e0131434.

https://doi.org/10.1371/journal.pone.0131434

PMid:26154343 PMCid:PMC4496051

Arefi R, Namazi MH, Safi M, Saadat H, Vakili H, Pishgahi M, et al. Value of Transverse Groove on the Earlobe and Hair Growth on the Ear to Predict the Risk for Coronary Artery Disease and Its Severity among Iranian Population, in Tehran City. GMJ.2020;9: e1443

https://doi.org/10.31661/gmj.v9i0.1443

Gopinath H, Upadya GM. Metabolic syndrome in androgenic alopecia. Indian J Dermatol Venereol Leprol. 2016;82(4):404-8.

https://doi.org/10.4103/0378-6323.174421

PMid:27279298

Banger HS, Malhotra SK, Singh S, Mahajan M. Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? Int J Trichology. 2015;7(4):141-7.

https://doi.org/10.4103/0974-7753.171566

PMid:26903742 PMCid:PMC4738480

Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466-77.e16.

https://doi.org/10.1016/j.jaad.2018.07.013

PMid:30031145

Cotton SG, Nixon JM, Carpenter RG, Evans DW. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J. 1972; 34(5):458-64.

https://doi.org/10.1136/hrt.34.5.458

PMid:5031636 PMCid:PMC486958

Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol. 1996; 143(7):651-7.

https://doi.org/10.1093/oxfordjournals.aje.a008797

PMid:8651226

Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA.1993;269:998-1003.

https://doi.org/10.1001/jama.1993.03500080046030

PMid:8429606

Herrera CR, D'Agostino RB, Gerstman BB, Bosco LA, Belanger AJ. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol. 1995; 142(8):828-33.

https://doi.org/10.1093/oxfordjournals.aje.a117722

PMid:7572959

Patil VB, Lunge SB. A study of correlation of angiographic evaluation of coronary artery disease with androgenetic alopecia-TricoHeart study. Int J Trichology. 2019; 11(6): 227-31.

https://doi.org/10.4103/ijt.ijt_111_19

PMid:32030055 PMCid:PMC6984045

Sharma L, Dubey A, Gupta PR, Agrawal A. Androgenetic alopecia and risk of coronary artery disease. Indian Dermatol Online J. 2013;4(4):283-7.

https://doi.org/10.4103/2229-5178.120638

PMid:24350006 PMCid:PMC3853891

Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol.2015;167(6):676-83.

https://doi.org/10.1093/aje/kwm365

PMid:18208984

Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2016;9(1):3.

https://doi.org/10.4103/0974-2077.178536

PMid:27081243 PMCid:PMC4812885

/Sari I, Aykent K, Davutoglu V, Yuce M, Ozer O, Kaplan M, et al. Association of male pattern baldness with angiographic coronaryartery disease severity and collateral development. Neth Heart J. 2015;23(5):265-74.

https://doi.org/10.1007/s12471-015-0688-3

PMid:25911010 PMCid:PMC4409596

Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol. 2001; 137(7):943-7.

Mansouri P, Mortazavi M, Eslami M, Mazinani M. Androgenetic alopecia and coronary artery disease in women. Dermatol Online J. 2005;11(3):2.

Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol 2011; 21(1):79-82.

https://doi.org/10.1684/ejd.2010.1193

PMid:21224180

Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010;163(2):371-7.

https://doi.org/10.1111/j.1365-2133.2010.09816.x

PMid:20426781

Ahouansou S, Le Toumelin P, Crickx B. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17(3):220-2.

Drabsch T, Holzapfel C, Stecher L, Petzold J, Skurk T, Hauner H. Associations between C-reactive protein, insulin sensitivity, and resting metabolic rate in adults: A mediator analysis. Front Endocrinol. 2018; 9: 556.

https://doi.org/10.3389/fendo.2018.00556

PMid:30294302 PMCid:PMC6158372

Hirsso P, Rajala U, Hiltunen L. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology. 2007;214(2):125-9.

https://doi.org/10.1159/000098570

PMid:17341860

Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 28;107(3):363-9.

https://doi.org/10.1161/01.CIR.0000053730.47739.3C

PMid:12551853

Al Edwan G, Bhindi B, Margel D, Chadwick K, Finelli A, Zlotta A, et al. The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy. Can Urol Assoc J. 2016;10(11-12):E424.

https://doi.org/10.5489/cuaj.3813

PMid:28096933 PMCid:PMC5167604

Refbacks

  • There are currently no refbacks.